Mortgage insurance provider MGIC Investment Corp. (NYSE: MTG) reported fourth-quarter revenue that missed analyst expectations, highlighting challenges in a cooling housing market. While earnings per share met consensus, flat year-over-year sales growth disappointed investors.
The professional staffing firm Kforce (NYSE:KFRC) reported fourth-quarter sales that edged past analyst expectations, yet its stock plunged 11.7% as earnings per share fell sharply short of estimates, highlighting ongoing challenges in a tightening labor market.
UPS's ambitious free cash flow target for 2026 appears to secure its hefty dividend, but a closer look reveals reliance on asset sales, deep cost cuts, and reduced capital investment—a strategy that may be mortgaging its long-term expansion.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
The Ermenegildo Zegna Group reported a resilient 2025, with full-year revenues reaching €1.92 billion. A strong fourth-quarter acceleration, driven by a 10% surge in direct-to-consumer sales, underscores the luxury group's strategic pivot away from wholesale. While the Americas and EMEA regions showed robust growth, Greater China remains a volatile market as the company navigates a planned leadership transition and industry headwinds.
ASML Holding NV has launched a massive new share repurchase program and reaffirmed strong sales guidance, as record AI-related equipment orders fuel optimism about the Dutch tech giant's central role in the semiconductor industry's future.
Moving to a state with no income tax might seem like a clear financial win, but the reality is more complex. Higher sales, property, and overall living costs in these states often offset the initial paycheck boost, creating a nuanced picture of who truly benefits.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
Via Transportation's shares have tumbled over 14% in the past month, trading near $23.25. While a discounted cash flow model suggests significant undervaluation, its price-to-sales ratio tells a more cautious story. Investors are left weighing aggressive growth projections against current market skepticism.
Sandra Harris is stepping down as CFO of Genesco, with CEO Mimi Vaughn taking on the role temporarily. The exit comes as the footwear retailer navigates a recent restructuring and revises its sales outlook amid challenging market conditions.
Iraq, UAE, Kazakhstan, and Oman have presented updated compensation schedules to the OPEC Secretariat, with Kazakhstan facing the steepest cuts—exceeding half a million barrels per day—through mid-2026 to atone for previous quota breaches.
Soybean markets opened February on a weaker note, extending losses from the previous week as sluggish export sales and advancing harvests in South America weigh on prices. Analysts are watching key USDA data for further direction.
Under new CEO Michael Leiters, Porsche is reportedly considering axing its planned all-electric 718 Boxster and Cayman line. The potential move, driven by development hurdles and soaring costs, signals a strategic recalibration as the automaker grapples with a sales slowdown in China and the financial weight of revising its EV roadmap.
Tesla's sales decline in Europe continues despite new lower-cost models, while industry buzz swirls around a hotly denied report of potential Ford-Xiaomi collaboration. Meanwhile, U.S. dealers show surprising pragmatism toward the EV transition.
Despite a modest price target reduction, Morgan Stanley reaffirms its Overweight rating on Wingstop, citing the chicken wing chain's robust unit expansion and system-wide sales momentum as key drivers for its 2026 outlook.
Russian pipeline gas exports to Europe via TurkStream increased in January, even as the EU finalizes a sweeping ban and Moscow's overall sales hit a multi-decade low, underscoring the continent's complex and uneven energy transition.
With the FIFA World Cup in North America, the Milano Cortina Winter Olympics, and a packed calendar of major events, 2026 is poised to be a landmark year for sports. Brands and retailers are deploying sophisticated strategies that prioritize cultural marketing and community engagement over mere sales spikes, navigating a landscape where consumer loyalty is won through storytelling, not just sponsorship.
Piper Sandler raises its price target on ImmunityBio, citing a near 700% surge in Anktiva sales and promising interim data from the QUILT trials that could support a major label expansion by 2027.
Despite promising mid-stage clinical data and billion-dollar sales potential for its mRNA pipeline, Arcturus Therapeutics (ARCT) is trading near its cash value—a signal the market is assigning near-zero odds to its success. This stark disconnect has analysts debating whether the biotech firm is a glaring mispricing or a high-risk bet.
Despite shrinking margins on new vehicle sales, Group 1 Automotive posted its highest-ever annual revenue, powered by robust growth in its service departments and finance operations. The auto retailer credits strategic investments in technician retention and a shift toward higher-margin repair work.
